Abstract
In 2017, Polish Biobanking Network was established in Poland, within BBMRI.pl project titled “Organization of Polish Biobanking Network within the Biobanking and Biomolecular Resources Research Infrastructure BBMRI-ERIC” as a strategic scientific infrastructure concept. One of the key elements of the project was the verification of the current status of QMS in the Polish biobanking institutions and the implementation of common solutions. The main goal was to indicate the current QMS level and determine the starting points for QMS development for each biobank of the Polish Biobanking Network (PBN). Within 3 years, 35 audit visits were performed. The current status and the level of QMS implementation in each biobank were assessed. Five hundred and seventy recommendations were prepared. The data was analyzed using Fischer Exact test to determine whether or not a significant association was observed. Three areas of analysis were covered: (1) BBMRI.pl status, (2) QMS implementation level and (3) private/public party, respectively. The results were discussed within 15 areas. Concluding remarks showed that some differences were observed in the case of subgroups analysis. There is convergence in QMS within the biobanks where Tissue Banks are located. Moreover, some discrepancies between the QMS implementation level in BBMRI.pl Consortium biobanks and PBN biobanks are observed. Nevertheless, the consortium members are obliged to prepare other biobanks willing to enter the PBN as Members/Observers or which already are in the PBN, so that they can meet the requirements of the quality management system that will enable efficient management of biobanking processes in these units. That is why some actions within BBMRI.pl projects are organized to help the whole biobanking community in Poland implement the harmonized solution.
Highlights
One of the main goals of biobanking is an increase in the efficiency and excellence of biomedical research, leading to the creation and development of new medical treatments (1)
The QM audit process is being noticed in other partner countries from BBMRI-ERIC such as Austria (16) and Finland
Recommendations indicate the lack of ability to quickly identify a critical device involved in the technological process (33.3%) and the lack of records for consumables and reagents used in the process (16.6%)
Summary
One of the main goals of biobanking is an increase in the efficiency and excellence of biomedical research, leading to the creation and development of new medical treatments (1). It can be done by facilitating access to quality-well-defined resources such as biological material (BM) samples with associated data. That guarantees constant monitoring of the obtained effects and ensures their high quality (5) It finds application in translational medicine, where the results of preclinical studies directly translate into patient therapy. These studies have to be of the highest quality and credibility as they determine the well-being of patients. The key to ensuring the quality of research is working on the highest quality of biological material and data—this is what biobanks are responsible for
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
